Screener
AbCellera Biologics Inc. ABCL Increase Decrease In Deferred Grant Income
Increase Decrease In Deferred Grant Income at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:IncreaseDecreaseInDeferredGrantIncome.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | Six months ended June 30, 2025 | Six months ended June 30, 2026 |
|---|---|---|
| Income taxes receivable | (7,588) | (8,024) |
| Accounts payable and accrued liabilities | (7,356) | (16,621) |
| Deferred revenue | 9,361 | 44,129 |
| Deferred grant income | (1,681) | (4,453) |
| Other assets | 13,450 | 1,838 |
| Net cash used in operating activities | (43,958) | (7,600) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (24,001) | (5,963) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s increase decrease in deferred grant income?
- AbCellera Biologics Inc. (ABCL) reported increase decrease in deferred grant income of $2.1M in Q2 2026.
- How has AbCellera Biologics Inc.'s increase decrease in deferred grant income changed year-over-year?
- AbCellera Biologics Inc.'s increase decrease in deferred grant income increased by 354.9% year-over-year, from $461K to $2.1M.
- What is the long-term trend for AbCellera Biologics Inc.'s increase decrease in deferred grant income?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s increase decrease in deferred grant income has grown at a -41.3% compound annual growth rate (CAGR), from -$30.72M to $3.64M.
- What does increase decrease in deferred grant income mean?
- This represents the change in grant funding received in advance of the related research and development activities being performed. An increase indicates that the company has secured funding for future projects that has not yet been recognized as revenue. It serves as a leading indicator of future research activity and government or partner support.
Ask your AI about AbCellera Biologics Inc.'s increase decrease in deferred grant income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude